← SynDRA
MIM-D3
SynDRA canonical compound SYN1958426 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | NGF | NTRK1 |
|---|
| Mechanism of action | tyrosine kinase partial agonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- TrkA agonist (ocular disease/Alzheimer's disease), Mimetogen
- Tavilermide
- tavilermida
- TAVILERMIDE [INN]
- TAVILERMIDE [USAN]
- TAVILERMIDE [WHO-DD]
- NMG938VJ6T
- tavilermidum
- RefChem:187555
- MIM-D 3
- Tavilermide [USAN:INN]
- UNII-NMG938VJ6T
- C24H32N6O11
- orb1706574
- SCHEMBL15468298
- SCHEMBL29354556
- MFCD30533429
- AKOS040742685
- CS-7495
- DA-78217
- HY-17622
- NS00073403
- G15960
- T17000
- MPS-429
- MIM D-3 HYDROCHLORIDE
- Tavilermide hydrochloride (USAN)
- RefChem:187556
- Tavilermide hydrochloride
- 7Q2C23X6YH
- MIM-D3 hydrochloride
- TAVILERMIDE HYDROCHLORIDE [WHO-DD]
- TAVILERMIDE HYDROCHLORIDE [USAN]
- Tavilermide Hydrochloride
- tavilermide hydrochloride
- D-3 hydrochloride
Look up MIM-D3 in the interactive SynDRA portal →